Benutzer: Gast  Login
Titel:

Long-term remission in schizophrenia and related psychoses with long-acting risperidone: results obtained in an open-label study with an observation period of 18 months.

Dokumenttyp:
Journal Article; Article
Autor(en):
Llorca, PM; Sacchetti, E; Lloyd, K; Kissling, W; Medori, R
Abstract:
OBJECTIVE: To monitor long-term symptomatic tolerability and remission in patients with stable but suboptimally treated psychoses after switching to risperidone long-acting injectable (RLAI). METHOD: This subgroup analysis of the Switch to Risperidone Microspheres (StoRMi) open-label trial followed up patients with psychoses who were converted to RLAI for a period of 18 months or until RLAI became commercially available in their country of residence. It included patients from seven European coun...     »
Zeitschriftentitel:
Int J Clin Pharmacol Ther
Jahr:
2008
Band / Volume:
46
Heft / Issue:
1
Seitenangaben Beitrag:
14-22
Sprache:
eng
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/18218293
Print-ISSN:
0946-1965
TUM Einrichtung:
Klinik und Poliklinik für Psychiatrie und Psychotherapie
 BibTeX